RALEIGH, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
